21.40
Doximity Inc stock is traded at $21.40, with a volume of 4.01M.
It is up +1.57% in the last 24 hours and down -11.57% over the past month.
Doximity Inc provides an online platform, which enables physicians and other healthcare professionals to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The Company's customers include pharmaceutical companies and health systems that connect with healthcare professionals through the Company's digital Marketing, Hiring, and Workflow Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential medical professional candidates.
See More
Previous Close:
$21.07
Open:
$21.1
24h Volume:
4.01M
Relative Volume:
1.08
Market Cap:
$3.91B
Revenue:
$637.78M
Net Income/Loss:
$239.40M
P/E Ratio:
17.97
EPS:
1.1909
Net Cash Flow:
$307.21M
1W Performance:
+7.32%
1M Performance:
-11.57%
6M Performance:
-58.40%
1Y Performance:
-58.80%
Doximity Inc Stock (DOCS) Company Profile
Name
Doximity Inc
Sector
Industry
Phone
(650) 549-4330
Address
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, BTSG, TEM, HQY, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
DOCS
Doximity Inc
|
21.40 | 3.85B | 637.78M | 239.40M | 307.21M | 1.1909 |
|
VEEV
Veeva Systems Inc
|
174.34 | 26.83B | 3.20B | 908.91M | 1.39B | 5.4168 |
|
BTSG
Brightspring Health Services Inc
|
61.68 | 11.80B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
50.47 | 9.21B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
HQY
Healthequity Inc
|
87.99 | 7.59B | 1.31B | 215.20M | 408.32M | 2.4627 |
|
HNGE
Hinge Health Inc
|
56.21 | 4.25B | 646.34M | -512.40M | 202.76M | -6.6871 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-20-26 | Downgrade | Truist | Buy → Hold |
| Apr-08-26 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-09-26 | Upgrade | Canaccord Genuity | Hold → Buy |
| Feb-06-26 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-20-26 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-09-26 | Initiated | RBC Capital Mkts | Outperform |
| Jan-08-26 | Upgrade | Truist | Hold → Buy |
| Dec-15-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-21-25 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Oct-27-25 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-10-25 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-01-25 | Downgrade | Goldman | Neutral → Sell |
| Jul-09-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jun-02-25 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-07-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-07-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Neutral |
| Nov-14-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Nov-13-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Nov-08-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Nov-08-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-09-24 | Upgrade | Needham | Hold → Buy |
| Jul-18-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Apr-25-24 | Upgrade | JP Morgan | Underweight → Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Jan-02-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-09-23 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-09-23 | Downgrade | Needham | Buy → Hold |
| Aug-03-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-01-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-31-22 | Initiated | Wells Fargo | Overweight |
| Oct-24-22 | Initiated | Evercore ISI | In-line |
| Oct-13-22 | Initiated | BTIG Research | Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-05-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-28-22 | Initiated | Berenberg | Buy |
| May-18-22 | Reiterated | BofA Securities | Neutral |
| May-18-22 | Reiterated | Goldman | Buy |
| May-18-22 | Reiterated | Guggenheim | Buy |
| May-18-22 | Reiterated | Jefferies | Buy |
| May-18-22 | Reiterated | Morgan Stanley | Equal-Weight |
| May-18-22 | Reiterated | Needham | Buy |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-04-22 | Initiated | BofA Securities | Neutral |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-14-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-17-21 | Initiated | Robert W. Baird | Outperform |
| Nov-10-21 | Reiterated | Canaccord Genuity | Buy |
| Nov-10-21 | Reiterated | Goldman | Neutral |
| Nov-10-21 | Reiterated | Morgan Stanley | Equal-Weight |
| Nov-10-21 | Reiterated | Needham | Buy |
| Nov-10-21 | Reiterated | Piper Sandler | Overweight |
| Aug-26-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-19-21 | Initiated | Canaccord Genuity | Buy |
| Jul-19-21 | Initiated | Goldman | Neutral |
| Jul-19-21 | Initiated | JP Morgan | Overweight |
| Jul-19-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-19-21 | Initiated | Piper Sandler | Overweight |
| Jul-19-21 | Initiated | Raymond James | Outperform |
| Jul-19-21 | Initiated | SVB Leerink | Outperform |
| Jul-19-21 | Initiated | William Blair | Outperform |
View All
Doximity Inc Stock (DOCS) Latest News
Doximity Stock Just Got Crushed. Is This a Rare Chance to Buy a High-Quality Growth Company on Sale? - AOL.com
Doximity hits an all-time low after Q4 results; KeyBanc downgrades - MSN
Doximity stock falls on Q4 earnings miss, revenues beat, margins down - MSN
Workday and Doximity Shares Are Soaring, What You Need To Know - Yahoo Finance
Doximity, Inc. (DOCS) Investigation: Bronstein, Gewirtz & Grossma - The National Law Review
OptimizeRx vs. Doximity: Which Digital Health Stock Is the Better Bet? - Yahoo Finance
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc.DOCS - PR Newswire
Doximity: A Strong Contender or Vulnerable to Disruption? - AOL.com
Ex-Doximity Exec Gets 2 Years For Insider Trading Scheme - Law360
Former Doximity executive sentenced in US to prison for insider trading - MLex
Doximity’s AI Investment Year Has Arrived: Is Doximity Stock Undervalued at $20 or Not - TIKR.com
Doximity Company Profile & Introduction - Moomoo
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Doximity, Inc. (DOCS) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Encourages Doximity, Inc. (DOCS) Investors to Inquire about Securities Investigation - ACCESS Newswire
Doximity's (NYSE:DOCS) Soft Earnings Are Actually Better Than They Appear - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Doximity, Inc. (DOCS) And Encourages Investors to Reach Out - ACCESS Newswire
Lawsuit probes Doximity over AI cost impact and revenue miss, shares drop 23%. - Pluang
Doximity AI Push Reshapes Healthcare Tech On Russell 1000 - Kalkine Media
Doximity, Inc. (DOCS) Stock Report: Analyst Ratings Point To A Promising 26% Upside - DirectorsTalk Interviews
Can Russell 1000 Pressure Weigh on Doximity Shares? - Kalkine Media
Doximity Stock Just Got Crushed. Is This a Rare Chance to Buy a High-Quality Growth Company on Sale? - The Motley Fool
Doximity’s SWOT analysis: stock faces pressure from AI spending, slowing growth - Investing.com Nigeria
Doximity shares hit record low as soft guidance and AI margin pressures spark 25% plunge - MSN
Baird downgrades Doximity (DOCS) - MSN
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Doximity, Inc. (DOCS) And Encourages Stockholders to Reach Out - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
Doximity forecasts fiscal 2027 revenue of $664M-$676M amid 'AI investment year' and softer pharma ad visibility - MSN
Handelsbanken Fonder AB Sells 315,900 Shares of Doximity, Inc. $DOCS - MarketBeat
Doximity to Present at the William Blair 46th Annual Growth Stock Conference - 01net
5 Revealing Analyst Questions From Doximity’s Q1 Earnings Call - Yahoo Finance
AI Reliance Poses Growing Operational, Regulatory, and Reputational Risks for Doximity - TipRanks
Doximity Leadership Shift And AI Push Reframe Growth And Valuation Outlook - Yahoo Finance
Stock market today: S&P 500, Dow, Nasdaq futures gain as Trump clears NVDA's H200 sales to China—Cisco Systems, Doximity in focus (updated) - MSN
Is It Time To Reassess Doximity (DOCS) After Its Sharp Share Price Slide? - simplywall.st
1,246 Doximity (DOCS) shares withheld to cover RSU taxes for interim PFO - Stock Titan
Doximity (NYSE: DOCS) CEO granted PSUs while shares withheld for tax - Stock Titan
Doximity (DOCS) outlines physician network, Clinical AI Suite and main business risks - Stock Titan
Why Are Doximity (DOCS) Shares Soaring Today - Yahoo Finance
J.P. Morgan Upgrades Doximity(DOCS.US) to Hold Rating, Cuts Target Price to $28 - Moomoo
Truist Financial Maintains Doximity(DOCS.US) With Hold Rating, Cuts Target Price to $19 - Moomoo
Doximity (DOCS) Q1 CY2026 Deep Dive: AI Investments Accelerate Amid Macro and Policy Headwinds - Yahoo Finance
Why Doximity (DOCS) Shares Are Sliding Today - Yahoo Finance
Northwestern Mutual Wealth Management Co. Purchases 1,298,492 Shares of Doximity, Inc. $DOCS - MarketBeat
Doximity (DOCS) Is Down 27.0% After Softer 2027 Outlook And Higher AI SpendWhat's Changed - Sahm
Doximity Stock Hits Day Low of $17.16 Amid Price Pressure - Markets Mojo
Another Wall Street analyst slashes Doximity stock price outlook - thestreet.com
Doximity Inc Stock (DOCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):